61 – 70 of 232
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Postprandial triglyceride levels rather than fat distribution may reflect early signs of disturbed fat metabolism in Iraqi immigrants
(
- Contribution to journal › Article
-
Mark
Estimating the Direct Effect between Dietary Macronutrients and Cardiometabolic Disease, Accounting for Mediation by Adiposity and Physical Activity
(
- Contribution to journal › Article
-
Mark
Impact of dronedarone on patients with atrial fibrillation and diabetes : A sub-analysis of the ATHENA and EURIDIS/ADONIS studies
(
- Contribution to journal › Article
-
Mark
Effect of Dronedarone in the Treatment of Atrial Fibrillation in the Asian Population : Post Hoc Analysis of the ATHENA Trial
(
- Contribution to journal › Article
-
Mark
P Wave Parameters and Indices : A Critical Appraisal of Clinical Utility, Challenges, and Future Research—A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology
(
- Contribution to journal › Scientific review
-
Mark
Air pollution and biomarkers of cardiovascular disease and inflammation in the Malmö Diet and Cancer cohort
(
- Contribution to journal › Article
-
Mark
High pro‑neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow‑up
(
- Contribution to journal › Article
-
Mark
Sugar-Coated. The role of sugar intake and cardiovascular disease development in the context of nutritional recommendations
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes
(
- Contribution to journal › Scientific review
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
(
- Contribution to journal › Article